Rheumatoid Arthritis Drugs Market to Become Worth US$ 26,758.6 Mn by 2026

Global Rheumatoid Arthritis Drugs Market – Snapshot

Rheumatoid arthritis is an autoimmune disorder that causes pain and inflammation in the joints. In this disease, the immune system mistakenly affects the joints, causing inflammation and pain in the joints throughout the body. Rheumatoid arthritis disease mostly affects the joints of the hand, wrists, elbows, knees, and ankles. Since rheumatoid arthritis also affects the cardiac and respiratory system, it is called a systemic disease. It usually affects the geriatric population, and the prevalence is higher in females as compared to males. Rheumatoid arthritis is also called a musculoskeletal disease, since it causes severe pain and deformity in one or more areas of the musculoskeletal system and in some indications, it exhibits symptoms of swelling, redness, and warmth in the affected areas.

Obtain Report Details @

https://www.transparencymarketresearch.com/rheumatoid-arthritis-drugs.html

In 2016, the global market for rheumatoid arthritis drugs was valued at US$ 19597.43 Mn. It is expected to expand at a CAGR of 2.96% from 2018 to 2026.

Several therapeutics and medication have been developed in recent years, to relieve and treat the symptoms of rheumatoid arthritis. Most commonly used drugs are disease modifying anti-rheumatic drugs (DMARDs), Nonsteroidal anti-inflammatory drugs (NSAID’s), corticosteroids, and biologic drugs. NSAIDs are widely utilized for the symptomatic treatment of rheumatic disorders. DMARDs are considered as the gold standard for the treatment of moderate to severe rheumatoid arthritis. Biologics account for a prominent market share, in terms of revenue, due to the considerably high cost of these medicines.

Request for Sample Copy of Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2011

The global rheumatoid arthritis drugs market can be segmented based on drug type, distribution channel, and geography. Furthermore, in terms of drug type, the market can be divided into disease-modifying anti-rheumatic drugs (DMARDs), non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and biologic response modifiers (biologics). The biologics segment is likely to account for a leading share of the global rheumatoid arthritis market in terms of revenue, during the forecast period, owing to the wide usage of drugs in severe rheumatoid disease. Biotechnological research and developments in rheumatoid arthritis drugs are estimated to boost the biologic drugs segment during the forecast period. Based on distribution channel, the market can be segmented into hospital pharmacy, retail pharmacy and online pharmacy. The hospital pharmacy segment is estimated to expand at a prominent growth rate during the forecast period, owing to the increase in number of hospitals and rise in preference of the geriatric patient population to undergo treatment at hospitals.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2011

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research

State Tower,

90 State Street, Suite 700

Albany, NY 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: www.transparencymarketresearch.com

My name is Pragya Tripathi and I work with the Digital Marketing and Editorial team of Transparency Market Research, a market intelligence firms based in India & Usa.